Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/120520
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Cancer-associated fibroblasts—heroes or villains? |
Author: | Gieniec, K.A. Butler, L.M. Worthley, D.L. Woods, S.L. |
Citation: | British Journal of Cancer, 2019; 121(4):293-302 |
Publisher: | Nature Publishing |
Issue Date: | 2019 |
ISSN: | 0007-0920 1532-1827 |
Statement of Responsibility: | Krystyna A. Gieniec, Lisa M. Butler, Daniel L. Worthley and Susan L. Woods |
Abstract: | Cancer-associated fibroblasts (CAFs) were originally presumed to represent a homogeneous population uniformly driving tumorigenesis, united by their morphology and peritumoural location. Our understanding of CAFs has since been shaped by sophisticated in vitro and in vivo experiments, pathological association and, more recently, ablation, and it is now widely appreciated that CAFs form a group of highly heterogeneous cells with no single overarching marker. Studies have demonstrated that the CAF population contains different subtypes based on the expression of marker proteins with the capacity to promote or inhibit cancer, with their biological role as accomplices or adversaries dependent on many factors, including the cancer stage. So, while CAFs have been endlessly shown to promote the growth, survival and spread of tumours via improvements in functionality and an altered secretome, they are also capable of retarding tumorigenesis via largely unknown mechanisms. It is important to reconcile these disparate results so that the functions of, or factors produced by, tumour-promoting subtypes can be specifically targeted to improve cancer patient outcomes. This review will dissect out CAF complexity and CAF-directed cancer treatment strategies in order to provide a case for future, rational therapies. |
Keywords: | Extracellular Matrix Animals Humans Mice Neoplasms Neoplasm Invasiveness Prognosis Energy Metabolism Phenotype Cancer-Associated Fibroblasts |
Rights: | © The Author(s), under exclusive licence to Cancer Research UK 2019. This work is published under the standard license to publish agreement. |
DOI: | 10.1038/s41416-019-0509-3 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1143414 http://purl.org/au-research/grants/nhmrc/1140236 |
Published version: | http://dx.doi.org/10.1038/s41416-019-0509-3 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_120520.pdf | Published version | 782.5 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.